23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
Studies previously showed that participation rates in a 401(k) plan are negatively impacted when the...
Read More >
Despite unprecedented disruptions to the court system from the COVID-19 pandemic, plaintiffs continu...
Read More >
On September 18, 2019, Governor Newson signed Assembly Bill No. 5 - legislation that changes the law...
Read More >
Medical ethicists and patient advocates are raising concerns about a big, costly, and often unsucces...
Read More >
Does a position that a company is holding for an employee out on FMLA leave an “open position” as ...
Read More >
The Internal Revenue Service (IRS) announced today cost-of-living adjustments affecting dollar limit...
Read More >